Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients
This study has been withdrawn prior to enrollment.
Study NCT00751608   Information provided by Novartis

First Received on September 11, 2008.   Last Updated on November 4, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Familial Hypercholesterolemia
Additional conditions recognized in this trial
Hypercholesterolemia
Hyperlipoproteinemia Type II
More general conditions related to this trial
Dyslipidemias
Genetic Diseases, Inborn
Hyperlipidemias
Hyperlipoproteinemias
Lipid Metabolism Disorders
Lipid Metabolism, Inborn Errors
Metabolic Diseases
Metabolism, Inborn Errors
Interventions listed in this trial
APL180
Placebo
Sponsors listed in this trial
Novartis Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services